Expanded portfolio of independently verified cell lines

DNA / RNA

Expanded portfolio of independently verified cell lines

28 May, 2026

Amsbio has expanded its range of authenticated cell lines, covering a broad spectrum of tumours, tissues, and species.

The updated portfolio includes more than 1,000 independently verified human and animal cell lines, alongside primary and stem cell models, offering researchers a wider selection of high-quality, well-characterised tools for experimental work.

Each cell line is rigorously validated to ensure genetic stability and consistent phenotypic performance, supporting high levels of reproducibility and confidence in research outcomes. Comprehensive documentation accompanies every line, reinforcing traceability and scientific integrity across applications.

To further strengthen reliability, all cell lines undergo stringent authentication, including multi-step identity verification and mycoplasma testing, helping to safeguard experimental accuracy.

These models are widely used across key areas such as gene regulation, protein–protein interactions, signalling pathways, and cellular differentiation, providing valuable insight into complex biological processes and supporting more physiologically relevant research compared with non-human systems.

More information online

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Another advance in river-based pathogen monitoring
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Non-invasive flowmeters for real-time monitoring
Explore more Arrow